Across disease status
How the selected metric shifts among healthy, primary, metastatic, and non-cancer disease samples.
| Group | Median | Samples |
|---|---|---|
| Unspecified | 1.1991-1.625 | 7,058 |
How the selected metric shifts among healthy, primary, metastatic, and non-cancer disease samples.
| Group | Median | Samples |
|---|---|---|
| Unspecified | 1.1991-1.625 | 7,058 |
How the same metric changes across tissue contexts after the current filters and tier are applied.
| Group | Median | Samples |
|---|---|---|
| Head and neck | 1.6621.356-2.22 | 92 |
| Lymphoid tissue | 1.4291.2-2 | 80 |
| Heart | 1.3791.081-2 | 1 |
| Adrenal gland | 1.3661.086-2.113 | 17 |
| Mixed sample organs | 1.3461.189-1.679 | 1 |
| Lung | 1.331-1.81 | 2,783 |
| Kidney | 1.331.056-1.709 | 25 |
| Pancreas | 1.2751.013-1.667 | 86 |
The combined comparison, useful for separating disease effects from tissue composition.
| Group | Median | Samples |
|---|---|---|
| Primary cancer x Breast | 1.170-1.937 | 1 |
| Healthy/control x Liver | 10-1.628 | 2 |
| Group | Metric | Mean | Samples | Datasets |
|---|---|---|---|---|
| Unspecified | Mean propensity | 1.263 | 7,058 | 55 |